Pfizer
Peter Brensilver's work experience includes multiple positions at Pfizer and a role as an Associate at Sidley Austin. Peter began working at Pfizer in 2010 as a Senior Corporate Counsel and eventually held roles such as Assistant General Counsel and Vice President & Chief Compliance Counsel. Peter'stenure at Pfizer included positions within different divisions of the company, such as Biopharmaceuticals Group and Essential Health. Prior to joining Pfizer, they worked as an Associate at Sidley Austin from 2002 to 2010.
Peter Brensilver earned a Bachelor of Arts degree from the University of Michigan in 1999. Peter then pursued higher education at The George Washington University Law School, where they obtained a Juris Doctor (J.D.) degree in 2002. Concurrently, they also attended The George Washington University School of Public Health and Health Services, earning a Master of Public Health degree with a focus on Health Policy in 2002.
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.